Skip to main
HQY

HealthEquity (HQY) Stock Forecast & Price Target

HealthEquity (HQY) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 36%
Buy 57%
Hold 0%
Sell 0%
Strong Sell 7%

Bulls say

HealthEquity is a market leader in the healthcare savings and spending industry, with strong financial performance and a growing HSA market. The company has demonstrated its ability to gain market share and maintain cost discipline, setting it up for potential long-term success. Despite near-term softness in the labor market, HQY's strong financials and promising outlook make it an attractive investment opportunity, with its recent virtual and in-person investor conferences highlighting its continued growth potential.

Bears say

HealthEquity is currently trading at a discount to its 5-year average multiple on both an EV/EBITDA and a P/E basis, but has a strong opportunity for TAM expansion due to regulatory tailwinds. The company's investment in AI has resulted in operational efficiency and cost savings, leading to a reduction in service costs and a strong outlook for recurring revenue. While near-term labor market dynamics may pose a challenge, the company's strong balance sheet and cash flows, along with its above-average growth and EBITDA margins, support a premium valuation in an expanding market.

HealthEquity (HQY) has been analyzed by 14 analysts, with a consensus rating of Buy. 36% of analysts recommend a Strong Buy, 57% recommend Buy, 0% suggest Holding, 0% advise Selling, and 7% predict a Strong Sell.

This aggregate rating is based on analysts' research of HealthEquity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About HealthEquity (HQY) Forecast

Analysts have given HealthEquity (HQY) a Buy based on their latest research and market trends.

According to 14 analysts, HealthEquity (HQY) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $115.36, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $115.36, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

HealthEquity (HQY)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.